Komipharm International Co., Ltd. (KOSDAQ:041960)

Komipharm International Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	12,448	14,820	10,805	11,992	15,048
Short-Term Investments	0	-0	-	23.08	2,057
Trading Asset Securities	10,000	-	-	1,914	-
Cash & Short-Term Investments	22,448	14,820	10,805	13,929	17,106
Cash Growth	51.47%	37.16%	-22.43%	-18.57%	-18.25%
Accounts Receivable	15,696	12,042	10,849	9,858	10,991
Other Receivables	1.34	47.67	25.07	150.49	225.26
Receivables	21,808	17,901	13,984	12,848	12,963
Inventory	14,566	14,901	16,254	14,176	13,837
Prepaid Expenses	181.04	1,723	327.35	183.49	145.63
Other Current Assets	932.06	667.43	221.76	315.9	624.05
Total Current Assets	59,935	50,012	41,593	41,452	44,675
Property, Plant & Equipment	55,784	64,239	66,522	70,141	72,063
Long-Term Investments	1,010	2,619	1,223	2,220	4,320
Other Intangible Assets	1,841	42.46	54.76	62.17	68.42
Long-Term Accounts Receivable	-	-	-	0	-
Long-Term Deferred Charges	2,052	1,172	753.46	847.1	616.92
Other Long-Term Assets	2,128	470.07	1,579	539.54	169.24
Total Assets	122,767	118,598	111,751	115,262	121,913
Accounts Payable	5,385	2,615	3,746	2,756	3,367
Accrued Expenses	309.88	437.59	274.77	329.23	283.02
Short-Term Debt	21,300	21,100	21,500	19,500	31,043
Current Portion of Long-Term Debt	13,248	19,162	13,141	731.05	1,731
Current Portion of Leases	185.04	245.64	174.68	154.46	160.86
Other Current Liabilities	5,805	8,668	2,211	2,213	2,752
Total Current Liabilities	46,233	52,228	41,047	25,685	39,338
Long-Term Debt	8,896	4,326	3,057	12,798	2,519
Long-Term Leases	209.6	267.91	258.85	237.84	214.54
Long-Term Deferred Tax Liabilities	1,761	1,761	1,741	1,741	1,741
Other Long-Term Liabilities	129.27	0	0	2,394	-
Total Liabilities	57,229	58,583	46,104	42,856	43,812
Common Stock	7,062	7,060	6,419	6,419	6,419
Additional Paid-In Capital	69,115	73,874	80,279	78,807	84,993
Retained Earnings	-10,670	-23,783	-24,804	-18,290	-13,831
Treasury Stock	-5,730	-2,052	-1,989	-989.46	-989.46
Comprehensive Income & Other	2,504	1,238	725.91	513.98	-315.96
Total Common Equity	62,280	56,338	60,631	66,460	76,275
Minority Interest	3,257	3,677	5,016	5,946	1,825
Shareholders' Equity	65,538	60,015	65,647	72,406	78,101
Total Liabilities & Equity	122,767	118,598	111,751	115,262	121,913
Total Debt	43,839	45,102	38,131	33,422	35,668
Net Cash (Debt)	-21,391	-30,282	-27,327	-19,493	-18,563
Net Cash Per Share	-306.96	-431.66	-388.82	-277.38	-264.39
Filing Date Shares Outstanding	69.7	70.15	70.12	70.28	70.28
Total Common Shares Outstanding	69.7	70.15	70.12	70.28	70.28
Working Capital	13,702	-2,217	545.11	15,768	5,337
Book Value Per Share	893.56	803.07	864.66	945.70	1085.37
Tangible Book Value	60,439	56,295	60,576	66,398	76,207
Tangible Book Value Per Share	867.14	802.46	863.88	944.81	1084.39
Land	14,149	17,998	17,903	18,678	18,561
Buildings	42,177	44,444	44,337	44,359	44,029
Machinery	26,410	25,514	25,146	24,625	24,231
Construction In Progress	9,894	10,804	10,719	10,719	10,361

Source: S&P Global Market Intelligence. Standard template. Financial Sources.